Key Segmentation
By Vector Type
-
Adeno-Associated Virus (AAV)
-
Lentivirus
-
Adenovirus
-
Retrovirus
-
Others
By Workflow
-
Downstream Processing
-
Upstream Processing
-
Fill & Finish
-
Others
By Application
-
Gene Therapy Development
-
Cell Therapy Research
-
Vaccine Development
-
Others
By End-User
-
Biotech & Pharma Companies
-
Academic & Research Institutes
-
Contract Research Organizations (CROs)
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated the Viral Vector Production (Research-use) Market in 2025.
The Adeno-Associated Virus (AAV) segment dominated the Viral Vector Production (Research-use) Market in 2025.
Rapid expansion of gene therapy and cell therapy pipelines is the primary growth driver of the Viral Vector Production (Research-use) Market.
The Viral Vector Production (Research-use) Market was valued at USD 1.95 billion in 2025.
The Viral Vector Production (Research-use) Market is expected to grow at a CAGR of 15.64% from 2026 to 2035.